These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9481038)

  • 41. The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    Eur J Med Chem; 2017 Jul; 135():196-203. PubMed ID: 28456030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of enantiomerically pure pyrrolyl-oxazolidinones as a new class of potent and selective monoamine oxidase type A inhibitors.
    Mai A; Artico M; Esposito M; Ragno R; Sbardella G; Massa S
    Farmaco; 2003 Mar; 58(3):231-41. PubMed ID: 12620419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
    Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
    Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates.
    Ding CZ; Lu X; Nishimura K; Silverman RB
    J Med Chem; 1993 Jun; 36(12):1711-5. PubMed ID: 8510099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
    Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
    Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
    Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
    Park HR; Kim J; Kim T; Jo S; Yeom M; Moon B; Choo IH; Lee J; Lim EJ; Park KD; Min SJ; Nam G; Keum G; Lee CJ; Choo H
    Bioorg Med Chem; 2013 Sep; 21(17):5480-7. PubMed ID: 23810676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selected furanochalcones as inhibitors of monoamine oxidase.
    Robinson SJ; Petzer JP; Petzer A; Bergh JJ; Lourens AC
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4985-9. PubMed ID: 23860591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs.
    Chaurasiya ND; Ganesan S; Nanayakkara NP; Dias LR; Walker LA; Tekwani BL
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1701-4. PubMed ID: 22264472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives.
    Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Petzer JP; Firgang SI; Suponitsky KY
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1206-11. PubMed ID: 25701250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities.
    Kumar B; Gupta VP; Kumar V
    Curr Drug Targets; 2017; 18(1):87-97. PubMed ID: 26648064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies.
    Khattab SN; Hassan SY; Bekhit AA; El Massry AM; Langer V; Amer A
    Eur J Med Chem; 2010 Oct; 45(10):4479-89. PubMed ID: 20708306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
    Strydom B; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of monoamine oxidase by benzoxathiolone analogues.
    Mostert S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.
    Geldenhuys WJ; Funk MO; Van der Schyf CJ; Carroll RT
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1380-3. PubMed ID: 22225638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Computer modelling of monoaminoxidases].
    Veselovsky AV; Ivanov AS; Medvedev AE
    Biomed Khim; 2015; 61(2):265-71. PubMed ID: 25978392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.